Iovance grants inducement stock options for 140,860 shares at $3.91 each

Iovance Biotherapeutics Inc

Iovance Biotherapeutics Inc

IOVA

0.00
  • Iovance Biotherapeutics granted inducement stock options covering 140,860 common shares to 27 new, non-executive employees on June 18, 2026.
  • Options carry an exercise price of USD 3.91 per share, set at the stock’s closing price on the grant date.
  • Vesting runs over three years, with one-third vesting on the first anniversary of the employee’s start date.
  • The remainder vests in eight quarterly installments over the following two years, contingent on continued employment.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Iovance Biotherapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606191715PRIMZONEFULLFEED9749757) on June 19, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.